Literature DB >> 2862170

Lithium in the treatment of mania.

S P Tyrer.   

Abstract

Lithium is clearly more effective than placebo in the treatment of mania but the delay in its action requires that alternative drugs be used in the control of the acute episode. This review examines the comparative effects of lithium and neuroleptics and the combination of lithium with (i) haloperidol, (ii) carbamazepine and (iii) L-tryptophan in the treatment of mania. The administration of lithium and carbamazepine together seems to be particularly advantageous in the treatment of manic states refractory to lithium. Features that predict a good response to lithium in mania are described and a brief description of the management of the manic patient given. It is argued that stable premorbid personality is associated with good response in this condition.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2862170     DOI: 10.1016/0165-0327(85)90023-0

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  3 in total

Review 1.  Practical clinical pharmacology. Therapeutic drug monitoring and clinical trials.

Authors:  M J Brodie; J Feely
Journal:  Br Med J (Clin Res Ed)       Date:  1988-04-16

Review 2.  The Bech-Rafaelsen Mania Scale in clinical trials of therapies for bipolar disorder: a 20-year review of its use as an outcome measure.

Authors:  Per Bech
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

Review 3.  Rhythm and blues. Neurochemical, neuropharmacological and neuropsychological implications of a hypothesis of circadian rhythm dysfunction in the affective disorders.

Authors:  D Healy
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.